Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Aignostics delivers AI-powered tissue analysis to improve drug development and patient outcomes, providing validated pathology insights. Its offerings include Pathology Foundation Models and the Atlas H&E-TME product for comprehensive tumor microenvironment profiling, plus services for target & biomarker discovery, translational research, and digital diagnostics. The company leverages multimodal data from 30 million+ patient samples, collaborates with leading academic and industry partners, and maintains ISO 13485/27001 certification with a GCP-ready clinical trial platform.
Parse Score
Sources
wewillcure.com shapes more of what AI says about Aignostics than any other source, at 38% of its citations.
aignostics.com · diagnexia.com · asklepieiahealth.com · avitia.bio
Excerpts where Aignostics appeared in the AI's answer

Aignostics builds AI-powered precision diagnostics by turning routine pathology slides into deep spatial biology insights.

Aignostics Uses AI-powered precision pathology to translate tissue morphology and spatial biology into actionable diagnostic insights